Dr. Amanda A. Westlake, MD

Dr. Westlake practices at Northeast Endoscopy Center - Lowell in Lowell, Massachusetts.

Dr. Westlake's NPI, 1154687820, was assigned on April 7, 2012. Dr. Westlake holds Massachusetts license 270261.

Dr. Westlake's primary practice is Northeast Endoscopy Center - Lowell, at 59 Lowes Way, Lowell, MA 01852. The practice phone is (978) 349-2146.

Dr. Westlake's primary practice is Northeast Endoscopy Center - Lowell in Lowell, Massachusetts. Dr. Westlake is also affiliated with Baystate Medical Center. The medical group on file is Baystate Medical Practices. Dmand AI also links Dr. Westlake to 1 more behavioral health center and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Westlake practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Westlake's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Westlake is licensed in Massachusetts.

CMS data shows 91 Medicare services from Dr. Westlake across 2 procedure codes in 2024, all of them office visits, for 48 Medicare patients. Medicare paid $6,963 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 48 Medicare patients who saw Dr. Westlake in 2024. The largest group is 65 to 74, with 29 patients. 58% of them have high blood pressure, and 44% have diabetes. Their average risk score is 2.33, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Westlake's median patient age at 65, with 53% women.

In 2024, Dr. Westlake wrote 6,848 Medicare Part D claims for 254 patients. 70% of them were for generic drugs. CMS names the drug for 6,251 of them, across 120 drugs with 11 or more claims each, at $3,080,406 in total drug cost. In 2023, CMS named 6,046 claims across 122 drugs.

Dr. Westlake accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 2 general payments to Dr. Westlake from 2 drug and device companies from 2022 to 2024. Education make up the largest share, 51% of the total. Merck Sharp & Dohme Corporation paid the most, $18.